# Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo

> **NCT03371758** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 40 (estimated)

## Conditions studied

- Autophagy

## Interventions

- **OTHER:** skin biopsy

## Key facts

- **NCT ID:** NCT03371758
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371758, "Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03371758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*